Our mission
Our mission is to revolutionize the detection and diagnosis of skin anomalies. Utilizing advanced convolutional neural networks (CNN) and deep learning algorithms, our innovative machines meticulously analyze beauty spots and moles to identify potential malignancies.
By harnessing the power of AI, we strive to reduce the time, cost, and uncertainty associated with traditional diagnostic methods. We are committed to enhancing early detection and improving outcomes for patients through precise, real-time assessments that support timely interventions and personalized treatment plans.
Additionally, we aim to increase public awareness about skin health by providing accessible tools that encourage proactive self-examinations and regular check-ups. At the core of our mission is the belief that everyone deserves access to reliable, state-of-the-art healthcare solutions.
Our vision
We envision a world where technology and healthcare work seamlessly together to prevent and detect skin cancer at its earliest stages.
By integrating cutting-edge AI technology with dermatological expertise, we aim to set the standard for AI-driven diagnostics, continually improving our technology to benefit millions globally. Our goal is to create a future where every individual has the means to monitor and protect their skin health with unparalleled accuracy and ease.
We aspire to be at the forefront of innovation in medical technology, providing solutions that bridge the gap between complex medical diagnostics and everyday accessibility.
Our team
Dermagnose is powered by a passionate and diverse team from top universities, specializing in AI, machine learning, computer science, business innovation, and software engineering. Our goal is to revolutionize dermatological diagnostics with cutting-edge technology.
We develop and refine advanced algorithms to create accurate and user-friendly diagnostic tools, focusing on accessible and reliable early skin cancer detection for healthcare professionals and patients.
We aim to remain at the forefront of technological advancements, continuously enhancing our solutions. United by a shared vision, we strive to improve global health by revolutionizing skin health diagnostics, enhancing early detection, and improving treatment outcomes. Driven by innovation, we are dedicated to making a positive impact on the world.
Co-Founder
Alan Grądecki
Leads the development and enhancement of the Dermagnose device, software, database, and deep learning model, ensuring high standards of quality, usability, and performance. He is responsible for integrating advanced CNN technology, developing user-friendly software, managing secure databases, and optimizing deep learning algorithms to provide accurate and reliable dermatological diagnostics.
Graduate of Control Engineering and Robotics & Computer Science at Poznan University of Technology.
Co-Founder
Aleksander Świecki
Oversees the company’s development, partnerships, and investments in technology, driving growth and innovation. He is responsible for establishing strategic alliances, securing funding, and ensuring that technological advancements align with the company’s goals and mission.
Graduate of Entrepreneurship and Business Innovation at Tilburg University and Prague University of Economics and Business.
Co-Founder
Szymon Gogulski
Controls the development and continuous improvement of the Dermagnose device, software, database, and deep learning models, maintaining high standards of quality, usability, and performance. He is integrating cutting-edge CNN technology, creating intuitive software, managing secure databases, and refining deep learning algorithms to ensure precise and reliable dermatological diagnostics.
Graduate of Control Engineering and Robotics at Poznan University of Technology.
Our journey
Dermagnose was born out of a need to bridge the gap between advanced AI technology and practical healthcare solutions. Since our inception, we have been committed to research and development, constantly refining our algorithms and expanding our knowledge base. Our journey is marked by innovation, collaboration, and an unwavering commitment to improving patient outcomes.
Our story began at universities, where a group of graduate students saw the potential of AI in dermatological diagnostics. Driven by a shared vision, we developed a solution for early and accurate skin cancer detection. Early on, we built a strong foundation in AI and machine learning through extensive research and experimentation. Despite facing challenges, our determination and resilience have driven us to push the boundaries of what’s possible. Each obstacle has strengthened our resolve and commitment to our mission.
Today, Dermagnose aims to stand at the forefront of AI-driven dermatological diagnostics. We remain dedicated to continuous improvement and innovation, aiming to expand our reach, establish meaningful partnerships, and integrate our technology into routine healthcare practices. Our journey is a testament to innovation, collaboration, and a commitment to improving global health.
Get involved!
Join us on our mission to revolutionize dermatological diagnostics! Whether you're a healthcare professional, researcher, industry partner, investor, student, or patient, we welcome you to be part of our journey!
We are excited to hear from you and explore how we can work together. Join us in making a significant impact on global health through innovation and collaboration.
Get involved today and be part of the change!
